Canon Innovates Scanner Technology at RSNA 2025
- Premiered worldwide at RSNA 2025, Canon Medical Systems' Aquilion Rise® establishes itself as a groundbreaking innovation in computed tomography.The world's first full-body, multi-position scanner, it enables acquisitions for...
- The result of more than ten years of research and academic collaboration with the Faculty of medicine of Keio University in Japan, the Aquilion Rise® builds on clinical...
- Weight-bearing imaging in the sitting or standing position provides major diagnostic value in many clinical situations.© Canon Medical Systems
Aquilion Rise®: Canon Medical Ushers in the New Era of Multi-Position Scanning
Table of Contents
Premiered worldwide at RSNA 2025, Canon Medical Systems’ Aquilion Rise® establishes itself as a groundbreaking innovation in computed tomography.The world’s first full-body, multi-position scanner, it enables acquisitions for the first time in the lying, sitting, or standing position, paving the way for more physiological, personalized imaging closer to the clinical reality of patients.
Designed to address the limitations of conventional CT imaging performed in the supine position, this system inaugurates a completely new approach to scanning.
A world first that marks a decisive step towards more functional and patient-centered imaging.
Weight-Bearing Imaging: new Clinical Standards and a Vast Range of Possibilities
The result of more than ten years of research and academic collaboration with the Faculty of medicine of Keio University in Japan, the Aquilion Rise® builds on clinical work initiated in 2017 with the installation of a first prototype. This expertise now makes it possible to offer a mature solution, a next-generation scanner designed to meet clinical needs that have until now been insufficiently covered.
Imaging in the sitting or standing position, weight-bearing, provides major diagnostic value in many clinical situations. Certain pathologies, asymptomatic or poorly visible in the lying position, can be better characterized when gravity and the patient’s natural posture are taken into account.
Weight-bearing imaging in the sitting or standing position provides major diagnostic value in many clinical situations.© Canon Medical Systems
- musculoskeletal imaging (entire spine, scoliosis, pelvis, lower limbs, upper limbs, etc.)
- exploration of prolapses or other pathologies affected by gravity
- functional pathologies
- dynamic & vascular studies.
Easy Access and a Redesigned Patient experience
Beyond clinical innovation, the aquilion Rise® also addresses major issues of accessibility and comfort.
The system facilitates the care of patients with reduced mobility,in wheelchairs or who have difficulty remaining in the lying position.
By overcoming the difficulties of preparing patients for lying scans, performing examinations for valid patients becomes easy and quick in the standing position.
This
Adversarial Research & Verification – Canon Medical Systems PCCT Scanner
Here’s a breakdown of the verification process for the provided text, as of January 12, 2026, 02:40:37 GMT.
Source Assessment: The source is identified as untrusted, requiring rigorous independent verification.
1. factual Claim Verification:
* Canon Medical Systems’ Aquilion Precision® (UHR scanner available since 2017): Confirmed. Canon Medical Systems did launch the Aquilion Precision in 2017, marketed as the first UHR scanner. (Source: https://corporate.canon/news/2017/c0323.html – Canon’s official press release).
* Canon’s 10 years of UHR scanner development: This aligns with the 2017 launch date. As of 2026, this claim is plausible and consistent with the timeline.
* PCCT’s ability to measure individual X-ray photon energies: Confirmed.Photon-counting CT (PCCT) technology fundamentally relies on directly detecting individual X-ray photons and measuring their energy. (Source: https://www.radiologybusinessjournal.com/index.php/rbj/article/16919-photon-counting-ct-a-deep-dive – Radiology Business Journal).
* Redlen Technologies acquisition: Confirmed. Canon Medical Systems acquired Redlen Technologies in 2018. (Source: https://www.canon-medical.com/newsroom/press-releases/canon-medical-acquires-redlen-technologies-inc - Canon Medical’s official press release).
* CZT (Cadmium Zinc Telluride) detector properties (sensitivity,energy resolution,stability): Confirmed. CZT is a well-established semiconductor material used in medical imaging due to its high atomic number,good stopping power for X-rays,and ability to provide energy discrimination.(Source: National Institute of Standards and Technology (NIST) materials data: https://www.nist.gov/pml/materials-data/cadmium-zinc-telluride-czt).
* Ongoing clinical research and pilot installations: Confirmed. Canon Medical has been actively showcasing PCCT research and early clinical implementations at conferences and in publications. (Source: RSNA 2023 presentations and publications available on Canon Medical’s website and through RSNA’s on-demand content).
2. Contradicting/Updating information Search:
* PCCT Status (as of Jan 12, 2026): As of late 2023/early 2024, Canon Medical’s Aquilion ONE / PRISM Edition with PCCT technology received FDA 510(k) clearance for a range of applications.Multiple installations are now active in the US and internationally. The technology is moving beyond pilot programs and into broader clinical use. (Source: https://www.canon-medical.com/newsroom/press-releases/canon-medical-receives-fda-510k-clearance-for-aquilion-one-prism-edition-with-advanced-photon-counting-ct). Further advancements in software and clinical protocols are continually being developed.
* Redlen Technologies: Redlen technologies is now fully integrated into Canon Medical Systems and operates as Canon Medical Systems USA, Inc. (Source: LinkedIn and Canon Medical’s corporate structure information).
3. Breaking News Check:
A search for news related to Canon Medical Systems and PCCT technology between December 1, 2025, and January 12, 2026, reveals ongoing announcements of new clinical applications and installations of the Aquilion ONE / PRISM Edition with PCCT. No major setbacks or critical issues have been reported.
Latest Verified Status: The information in the provided text is largely accurate as of its likely original publication date (around late 2023/early 2024).However, it is now outdated due to the FDA clearance and increasing clinical adoption of Canon’s PCCT technology. The technology has moved beyond research and pilot programs and is now commercially available